BioImagene receives UL Certification for the iScan Slide Scanner
Cupertino, CA, Sep 9, 2008
BioImagene, the
leader in providing affordable, innovative digital pathology
solutions for cancer diagnosis and pre clinical research,
announced today that its iScan™ Slide Scanner has
received the prestigious Underwriter Laboratories (UL) Listing.
The UL Listing confirms that the iScan complies with the
UL standard for laboratory equipment, for use in health care
applications. The UL certification applies in both the US
and Canada.
The iScan is
the new, affordable desktop slide scanner from BioImagene
for digitizing whole tissue slides in a pathology laboratory.
It is fully automated and combines high speed scanning of
up to 160 slides with superior image quality up to 40x. It
is integrated with BioImagene’s digital pathology software
to provide pathologists and researchers with an easy, web-based
solution for viewing, managing, reporting, archiving and
sharing tissue images. The iScan Slide Scanner has already
received the CE mark for Europe.
“At BioImagene we believe in stringent testing to
ensure optimal performance of our products”, said Gregory
Loney, VP of Instrumentation, Engineering. “This
UL certification provides the highest assurance to our customers
that the iScan Slide Scanner will perform in a safe manner
when used in the clinical, hospital and research markets.”
About Underwriters Laboratories,
Inc. (UL)
Underwriters Laboratories Inc. (UL) is an independent,
not-for-profit product safety certification organization
that has been testing products for more than 110 years. UL
is the trusted source across the globe for product compliance
benefitting a range of customers - from manufacturers and
retailers to consumers and regulating bodies. For more information,
visit the UL Web site at www.ul.com.
About BioImagene, Inc.
BioImagene is a leading provider of
total digital pathology solutions for applications including
clinical diagnostics and drug discovery. BioImagene products
are FDA -cleared for specific clinical applications, and
are intended for research use for other applications. www.bioimagene.com.
Media contact: Suchi Parth, 408 207 4285
|
